By taking the patient's well-being into account, manufacturers can improve their productivity.
Aug 1, 2008
By:
Kim Thomas, Darren Hieber
|
Manufacturers of biopharmaceuticals can improve productivity by taking patient wellness into account.
What pharmaceutical companies should do to achieve their strategic goals.
Jul 1, 2008
By:
Tarja Mottram
|
Best practices a pharmaceutical company can follow to execute their strategy sucessfully.
Under the current regulations, there is no system that allows a firm to openly deal with validation failures
Jun 1, 2008
By:
Stephan Krause, PhD
|
The industry needs to open up to validation failures.
Recent events have highlighted the need for action with regards to how we handle materials from abroad.
May 1, 2008
By:
Paula J. Shadle, PhD
|
Recent problems with food and pharmaceutical ingredients sourced from China highlight a major disadvantage of our complex international supply chains for food and drug ingredients. A global supply chain offers more opportunities for accidental contamination as well as intentional adulteration and counterfeiting. Sticking to minimal requirements may not be enough.
Apr 1, 2008
By:
Marta Jimenez-Aquino, David W. Husman, PhD, Thomas Feyerabend, Jr.
|
Engaging executive leadership in the quality process is the key to compliance success.
Mar 1, 2008
By:
Warren Perry
|
The expanding globalization of the industry poses a challenge for international enforcement.
Both innovator and generics companies are using analytics to support comparability arguments.
Feb 1, 2008
By:
Jeffrey R. Mazzeo
|
Both innovator and generics companies are using analytics to support comparability arguments.
Self-awareness of IP protection among Chinese pharmaceutical companies is increasing
Jan 1, 2008
By:
Jim J. Zhang
|
The Chinese government is making consistent efforts to strengthen IP protection.
Personalized medicines could become more popular than top earning drugs that face patent expiry
Dec 1, 2007
By:
Nafees Malik
|
Eighty drugs will lose patent protection between 2007 and 2011.
